fda tirzepatide compound approval sets compounding deadlines as shortage ends Impurity in Some Compounded Tirzepatide
Description
Just a woman who figured some things out the hard way
Tirzepatide (Mounjaro, Zepbound) is a once-weekly subcutaneous injection for type 2 diabetes and chronic weight management
These benefits make tirzepatide a promising option, especially for patients who have not achieved their goals with other medications
It might lower your cost to around $25 a month
Rare but serious side effects include pancreatitis, gallbladder problems, hypoglycemia (especially in patients with diabetes on other medications), and severe allergic reactions
Constipation can be managed with increased fiber and hydration
